Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Rises By 2,335.2%

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 5,170,000 shares, an increase of 2,335.2% from the June 15th total of 212,300 shares. Currently, 18.1% of the company’s shares are short sold. Based on an average trading volume of 9,490,000 shares, the short-interest ratio is presently 0.5 days.

NLS Pharmaceutics Price Performance

Shares of NASDAQ:NLSP opened at $0.20 on Friday. The business has a 50-day moving average price of $0.17 and a 200 day moving average price of $0.28. NLS Pharmaceutics has a 12-month low of $0.11 and a 12-month high of $1.21.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).